Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 1, Pages 85-93
Publisher
Springer Nature
Online
2014-05-28
DOI
10.1038/bjc.2014.272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death
- (2013) Gang Cheng et al. BMC CANCER
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- (2013) Barbara Salani et al. Scientific Reports
- Metformin inhibits inflammatory response via AMPK–PTEN pathway in vascular smooth muscle cells
- (2012) Sun Ae Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
- (2012) G. Cheng et al. CANCER RESEARCH
- Systemic treatment of advanced pancreatic cancer
- (2012) Volker Heinemann et al. CANCER TREATMENT REVIEWS
- Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
- (2012) Ralph J. DeBerardinis et al. CELL
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
- (2012) A. Le et al. CLINICAL CANCER RESEARCH
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- Alterations in bioenergetic function induced by Parkinson’s disease mimetic compounds: lack of correlation with superoxide generation
- (2012) Brian P. Dranka et al. JOURNAL OF NEUROCHEMISTRY
- Energy metabolism and proliferation in pancreatic carcinogenesis
- (2012) Ivonne Regel et al. LANGENBECKS ARCHIVES OF SURGERY
- Metabolic reprogramming of the tumor
- (2012) L M R Ferreira et al. ONCOGENE
- Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
- (2012) Dania Daye et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Assessing Treatment Effect in Pancreatic Cancer
- (2011) Douglas J Hartman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Relevance of the OCT1 transporter to the antineoplastic effect of biguanides
- (2011) Eric D. Segal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Understanding the benefit of metformin use in cancer treatment
- (2011) Ryan JO Dowling et al. BMC Medicine
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Targeting cancer metabolism – aiming at a tumour's sweet-spot
- (2011) Neil P. Jones et al. DRUG DISCOVERY TODAY
- Comparative Metabolic Flux Profiling of Melanoma Cell Lines
- (2011) David A. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting mitochondria as a therapeutic target in cancer
- (2011) Charles E. Wenner JOURNAL OF CELLULAR PHYSIOLOGY
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia
- (2011) Hsiu-Ni Kung et al. PLoS Genetics
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Phenotype and Genotype of Pancreatic Cancer Cell Lines
- (2010) Emily L. Deer et al. PANCREAS
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
- (2009) Divya Pathania et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy
- (2009) BS Dwarakanath et al. Future Oncology
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Pancreatic cancer: from molecular pathogenesis to targeted therapy
- (2008) Alexios Strimpakos et al. CANCER AND METASTASIS REVIEWS
- From delocalized lipophilic cations to hypoxia: Blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors
- (2008) Metin Kurtoglu et al. MOLECULAR NUTRITION & FOOD RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started